On World Ovarian Cancer Day, May 8, the Global Ovarian Cancer Research Consortium announces a second $1 million USD grant along with AWS compute support to power research that aims to improve ovarian cancer survival rates
On World Ovarian Cancer Day the Global Ovarian Cancer Research Consortium, of which Ovarian Cancer Research Alliance (OCRA) is a founding partner, today announced the launch of its second $1 million USD AI Accelerator Grant, a major research initiative designed to harness artificial intelligence and large-scale data to accelerate progress against ovarian cancer while promoting international collaboration.
The Consortium’s AI Accelerator Grants are designed to support innovative, data-intensive research projects that leverage cutting-edge computational approaches to address some of the most pressing challenges in ovarian cancer, including prevention, initiation, and early detection; the tumor ecosystem; and treatment resistance. The initiative builds on the Consortium’s mission to unite global expertise and resources to drive faster, more meaningful breakthroughs and advance research that improves survival and outcomes for patients worldwide.
AI is already revolutionizing cancer diagnoses—from breast to brain, skin to thyroid—with stunning advances. But ovarian cancer has yet to realize the full power of this transformation–funding has lagged behind other diseases despite the high mortality rate and rising number of diagnoses. The Consortium is committed to changing this, launching their first $1 million initiative last year. Twenty-one international teams, each comprised of researchers from Australia, Canada, the United Kingdom and the United States competed, with the first grant announced earlier this year.
This is about fundamentally changing the pace and possibility of ovarian cancer research,” said Audra Moran, President and CEO of Ovarian Cancer Research Alliance (OCRA). “By combining global collaboration, advanced AI, and the power of shared data, we are creating an environment where discoveries can happen faster—and where each insight has the potential to benefit patients everywhere. On World Ovarian Cancer Day, along with our global partners, we are proud to take another step toward a future where better outcomes are not the exception, but the expectation.
As part of the grant, selected researchers will receive in-kind cloud compute credits from Amazon Web Services (AWS) to use within Ovarian Cancer Research Alliance’s AI-enabled, international, collaborative research platform. By anchoring the work within this shared ecosystem, the Consortium ensures that research funded by the AI Accelerator Grant is conducted in a scalable setting that enables real-time data analysis, cross-institutional collaboration, and the integration of diverse datasets. The Consortium is helping to transform how research is conducted, shifting from isolated efforts to a connected, global model of discovery.
The Global Ovarian Cancer Research Consortium includes Ovarian Cancer Research Alliance (United States), Ovarian Cancer Action (United Kingdom), Ovarian Cancer Canada (Canada), and The Ovarian Cancer Research Foundation (Australia). Recognizing the need for innovation and worldwide collaboration, the Consortium was created to accelerate progress by uniting stakeholders in collective action to advance collaboration, innovation, and investment in transformative research, promote data sharing, and address unmet needs and access gaps.
Letters of Intent for the AI Accelerator Grant open on May 8.
